These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10732856)

  • 1. Delayed onset of pulmonary hypertension associated with an appetite suppressant, mazindol: a case report.
    Hagiwara M; Tsuchida A; Hyakkoku M; Nishizato K; Asai T; Nozawa Y; Tsuchihashi K; Shimamoto K
    Jpn Circ J; 2000 Mar; 64(3):218-21. PubMed ID: 10732856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appetite-suppressant drugs and primary pulmonary hypertension.
    Fishman AP
    N Engl J Med; 1997 Feb; 336(7):511; author reply 512-3. PubMed ID: 9019650
    [No Abstract]   [Full Text] [Related]  

  • 3. Recreational use of aminorex and pulmonary hypertension.
    Gaine SP; Rubin LJ; Kmetzo JJ; Palevsky HI; Traill TA
    Chest; 2000 Nov; 118(5):1496-7. PubMed ID: 11083709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension.
    Frank H; Mlczoch J; Huber K; Schuster E; Gurtner HP; Kneussl M
    Chest; 1997 Sep; 112(3):714-21. PubMed ID: 9315805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mazindol (Teronac)- another anorectic drug.
    Drug Ther Bull; 1974 Dec; 12(26):101-2. PubMed ID: 4459058
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic pulmonary hypertension of vascular origin, plexogenic pulmonary arteriopathy and the appetite depressant aminorex: addenda to an epidemic].
    Gurtner HP
    Schweiz Med Wochenschr; 1985 Jun; 115(23):782-9contd. PubMed ID: 4023670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug induced pulmonary hypertension].
    Sato N; Nakanishi N
    Nihon Rinsho; 2001 Jun; 59(6):1197-202. PubMed ID: 11411136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminorex to Fen/Phen: an epidemic foretold.
    Tellier P
    Circulation; 1999 Dec; 100(25):e146; author reply e147. PubMed ID: 10604912
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary pulmonary hypertension: follow-up of patients with and without anorectic drug intake.
    Mlczoch J; Probst P; Szeless S; Kaindl F
    Cor Vasa; 1980; 22(4):251-7. PubMed ID: 7449394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term course of primary vascular pulmonary hypertension with and without intake of appetite depressants].
    Voss H; Feigel H; Bücking J
    Z Kardiol; 1983 Apr; 72(4):215-21. PubMed ID: 6868739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mazindol: a risk factor for pulmonary arterial hypertension?
    Konofal E; Benzouid C; Delclaux C; Lecendreux M; Hussey E
    Sleep Med; 2017 Jun; 34():168-169. PubMed ID: 28522087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anorectic drugs and pulmonary hypertension from the bedside to the bench.
    Michelakis ED; Weir EK
    Am J Med Sci; 2001 Apr; 321(4):292-9. PubMed ID: 11307870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction.
    Weir EK; Reeve HL; Huang JM; Michelakis E; Nelson DP; Hampl V; Archer SL
    Circulation; 1996 Nov; 94(9):2216-20. PubMed ID: 8901674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of pulmonary hypertension in patients with and without anorectic drug intake.
    Loogen F; Worth H; Schwan G; Goeckenjan G; Lösse B; Horstkotte D
    Cor Vasa; 1985; 27(2-3):111-24. PubMed ID: 4028729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.
    Abenhaim L; Moride Y; Brenot F; Rich S; Benichou J; Kurz X; Higenbottam T; Oakley C; Wouters E; Aubier M; Simonneau G; Bégaud B
    N Engl J Med; 1996 Aug; 335(9):609-16. PubMed ID: 8692238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs induced pulmonary arterial hypertension.
    Seferian A; Chaumais MC; Savale L; Günther S; Tubert-Bitter P; Humbert M; Montani D
    Presse Med; 2013 Sep; 42(9 Pt 2):e303-10. PubMed ID: 23972547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the role of serotonin in the pathogenesis of pulmonary hypertension induced by anorectic drugs; an experimental study in the isolated perfused rat lung, II. Fenfluramine, mazindol, mefenorex, phentermine and R 800.
    Seiler KU; Wassermann O; Wensky H
    Clin Exp Pharmacol Physiol; 1976; 3(4):323-30. PubMed ID: 975621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminorex and pulmonary hypertension. A review.
    Gurtner HP
    Cor Vasa; 1985; 27(2-3):160-71. PubMed ID: 3928246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminorex, dexfenfluramine, and primary pulmonary hypertension.
    Kramer MS; Lane DA
    J Clin Epidemiol; 1998 Apr; 51(4):361-4. PubMed ID: 9539893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anorexic preparations and primary pulmonary hypertension].
    Ugriumova MO
    Ter Arkh; 1976; 40(2):126-31. PubMed ID: 788209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.